FDA Investigator Elizabeth A Sheller
Elizabeth A Sheller has inspections in 1 countries as of 03 Oct 2023. Elizabeth A Sheller has collaborated with a combined 1622 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
44
Last Inspection Date:
03 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Abby M Miller,
Alan D Grupe,
Amber M Howell,
Ava M Bowman,
Barbara J Rincon,
Brenda K Alford,
Brenda L Reihing,
Brian E Thompson,
Bruce R Burrell,
Bryce E Mansfield,
Camille Bennett Hoffman,
Catherine J Laufmann,
Ce'nedra M Martin,
Celia L Hutchinstein,
Christopher E Rezendes,
Christopher R Czajka,
Colleen M Jones,
Crystal A Harlan,
Dan C Fisher,
David J Gomes,
David L Hunsaker,
Debra D Devlieger,
Devon M Shoop,
Elizabeth S Howell,
Eric C Milstead,
Erica R Mahone,
Harmon M Blanch,
Harmon M Buanch,
Hugh Grimoldby,
Ian J Thomson,
James I Vik,
James S Cartwright,
Jeanne M Weigheer,
Jeanne M Weishaar,
Jeannine K Wooten,
Jeff A Gard,
Jeffrey J Leclair,
Jim Cartwright,
Jinkee Mvila Binayug,
John A Hall,
John T Sproul,
Jonathan T Little,
Joseph M Hudak,
Katharine Chan,
Keishla M Arroyo Lopez,
Kevin Gerrit,
Kevin T Gerrity,
Kimberly J Proctor Jones,
Lenita R Silvera,
Lisa A Bowden,
Lisa K Capron,
Lori J Silverstein,
Margo C Jones,
Margo Cl Jones,
Mark E Imsland,
Mark E Moen,
Mark L Collins,
Matthew R Barr,
Michael H Antee,
Michael J Donovan,
Mikel T Wright,
Nancy E Byerly,
Nancy E Doyle,
Narahi J Alvarez Alcazar,
Othello G Capangpangan,
Paul F Rader,
Paul M Kawamoto,
Paula J Wilkerson,
Peter T Regan,
Philip E Ake,
Rebecca A Sletner,
Rebecca T Davis,
Richard A Martin,
Ronald E Gill,
S Lori Brown, PhD MPH,
Sandra K Wangen,
Sarah L Clark,
Savini,
Shahriar Rahmani,
Shelagh D Schopen,
State Agency,
Stephanie A Jameson,
Stephanie J Shaw,
Tara A Marshall,
Tara M Pianko,
Thomas C Mclean, CFS,
Timothy E Sample,
Tracy K Li,
Vitaliy N Guyvan,
Wayne F Larson,
Williamsra,
Willis L Hicks,
Xiaojun Yan,
Yvonne M Larsen
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more